TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity.
about
Recognition and Regulation of T Cells by NK Cells"Natural Regulators": NK Cells as Modulators of T Cell ImmunityILC1s in Tissue Inflammation and InfectionNK Cells in HIV DiseaseMaintenance of Immune Homeostasis through ILC/T Cell InteractionsGenomic Modifiers of Natural Killer Cells, Immune Responsiveness and Lymphoid Tissue Remodeling Together Increase Host Resistance to Viral InfectionType 1 Innate Lymphoid Cell Biology: Lessons Learnt from Natural Killer CellsBoosting vaccine efficacy the natural (killer) wayAcute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future DirectionsDepletion of B220(+)NK1.1(+) cells enhances the rejection of established melanoma by tumor-specific CD4(+) T cells.Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.Phenotype and functions of conventional and non-conventional NK cellsThe Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus InfectionNLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditionsNK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infectionMembrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biologyAnalysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease.Roles of natural killer cells in antiviral immunityTherapeutic applications of TRAIL receptor agonists in cancer and beyond.Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membraneTransforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.Differentiation and diversity of subsets in group 1 innate lymphoid cells.GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.Lymph node - an organ for T-cell activation and pathogen defense.Super natural killer cells that target metastases in the tumor draining lymph nodesT-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.Tissue-resident natural killer cells in the livers.Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?Innate immunity in Sjögren's syndrome.NFIL3 Expression Distinguishes Tissue-Resident NK Cells and Conventional NK-like Cells in the Mouse Submandibular Glands.Editorial: NK cell reaping of Tfh cells: reckless slaughter or sensible pruning?Virus Infection and Death Receptor-Mediated Apoptosis.Epigenetic changes found in uterine decidual and placental tissues can also be found in the breast cancer microenvironment of the same unique patient: description and potential interpretations.Liver-resident NK cells and their potential functions.Back to the drawing board: Understanding the complexity of hepatic innate lymphoid cells.The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s.
P2860
Q26742166-80692BAF-4B55-4563-BE7B-38470DFD49A0Q26744551-CF999CEE-12CB-41D1-B873-76AE3B61AB12Q26752285-26B6B51D-C33B-4C72-8CD4-6EEBD67DFCA4Q26752833-52A5A802-3607-4244-869F-328E3139A63AQ26796071-80ED3C2A-E629-4B85-8A5F-DCF0DCE36BDFQ27316041-021AA96A-479A-46C6-9E62-BC463A1322FAQ28066387-B47FA410-C0AD-4D0C-8DA5-A93AC5201701Q28084474-04143D7F-20DF-431B-A912-CF86B19EDC3AQ30275560-188E3180-6DCF-42ED-B08E-FFBEEB7B7DC6Q35506459-6063FE46-4C54-4B8D-81E4-B98370D146B2Q35858827-82644878-88D8-4BCE-B0F4-D521CF333A92Q36030989-518A5858-2D7C-43CE-87B2-8BCDCB3DA4CAQ36060315-C74A6657-BBB5-4C98-8BFE-E9ADE7CFE303Q36214992-ED401B58-330F-41F3-B625-573AE5D974AEQ36471225-1E4A20F6-33F2-4CDD-97CF-A871AB22AB8BQ36557780-7FDA15AF-866E-4532-8286-B6EB7CC42A2BQ36569520-724737F3-E5AA-4B93-82D2-55B7A512B1B4Q36608144-6AA870D0-53A6-4F41-A799-C17771336EEFQ36645343-99E54B51-6713-4BD7-ADF4-D37242785944Q36668368-5CF7C0CE-96B1-41EA-BAC5-FCEA574BA4FCQ36767761-CC5D5AD6-1BAF-469C-ADE2-1E6DBD66D22CQ37114025-FBBE09C0-C203-473E-80C0-0D2398DAD259Q37327815-FA03409D-AE10-4D35-84D6-50EF3420DD58Q37420965-4540BB76-9A1A-4058-A932-B2F1C650CAF7Q38582546-CB41CC4E-BD0A-4813-8798-ECFBAED9AF9CQ38727251-F375C8F7-E3A7-49B7-AA36-D1A27D3D63A0Q38762340-3A84F1A0-4AC6-4DF2-BDF2-2F615DC54F64Q38810913-8CE7860C-8A65-4A46-9678-9AACBB1EDD80Q38818477-698EF108-C0DA-4644-A983-8A1CADBE74E1Q38826175-291FB7F8-4442-41B4-AB55-2170585DD4C7Q39026625-1ACE7F4C-69DC-4536-A857-3A776BE0B6A6Q39144086-1F4B5D2C-1DCF-47F2-8A3F-3D5A7DFCE39DQ39232871-E224FF91-D32F-4731-9FA7-EADA28D2D125Q39493393-50BC2C15-97A1-4519-8F64-2E182D384D29Q45014555-4920E71B-0EC1-473B-A740-A2BDE2E34450Q45325588-2EB1D2A6-214A-4EC2-9E6C-D0CB81A4889AQ49787669-C6EEFF1A-418A-43B9-9037-5255354BBC06Q50049018-2A58B2B7-A834-4646-9873-18BF86E99315Q51531147-73E85BC1-84D9-4990-A8C0-BAE289057A28Q52625337-C33B99C0-583B-48D7-A24A-55C95BC9DDC8
P2860
TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
TRAIL+ NK cells control CD4+ T ...... fection to limit autoimmunity.
@en
type
label
TRAIL+ NK cells control CD4+ T ...... fection to limit autoimmunity.
@en
prefLabel
TRAIL+ NK cells control CD4+ T ...... fection to limit autoimmunity.
@en
P2093
P50
P1433
P1476
TRAIL+ NK cells control CD4+ T ...... nfection to limit autoimmunity
@en
P2093
Iona S Schuster
Lorraine A O'Reilly
Mariapia A Degli-Esposti
Matthew E Wikstrom
Mitali Manzur
P304
P356
10.1016/J.IMMUNI.2014.09.013
P407
P50
P577
2014-10-01T00:00:00Z